TSE Growth Market Index 814.89 -2.43 / Volume 0.2 billion 14.75 million shares / Trading value 145.5 billion yen.

TSE Growth Market 250 Index 635.44 -2.83 / Volume 0.1 billion 5.09 million shares / Trading value 97.2 billion yen.

Today's Growth Market saw both the TSE Growth Market Index and TSE Growth Market 250 Index continue to decline, with 187 stocks rising, 363 stocks falling, and 45 remaining unchanged.

Today's Growth Market showed a weak trend. The Dow average in the US market on the previous day, the 16th, fell for eight consecutive days. Expectations for additional rate cuts at the Federal Open Market Committee (FOMC) meeting in the middle of the week were liked, and the December Services PMI showed a high level not seen in about three years and an acceleration in the pace of expansion, causing an increase in the range. However, the Dow average, which has continued to decline, faced resistance at higher levels and fell slightly. On the other hand, the Nasdaq, driven by the rise of Apple, Alphabet, and Broadcom, remained steady and updated its all-time high.

Against the backdrop of the mixed close of the US stock market, the TSE Growth Market Index started lower after the opening. In the morning, the decline widened to 811 points. After that, it traded in the negative territory, but in the afternoon session, there was a trend of buybacks that briefly lifted it back into positive territory. However, the buying did not sustain, leading to a heavy downward trend before falling back into negative territory to close the trading day. With the upcoming meetings to determine monetary policy in Japan and the USA, trading was restrained, and the Emerging Markets also showed lackluster price movements. Individual stocks saw continued active buying while large market cap stocks were mixed in performance.

Individually, GLOE <9565>, which has been trending down recently, dropped by 12%, making it the top decliner. M Mart <4380> faced a 9% drop due to concerns over performance despite an increase in profits in the 2nd to 10th months. GMO TECH <6026> continued to be dominated by selling since the previous day, losing 7%. Among large market cap stocks, Trial <141A> and GENDA <9166> trended weakly, with Oncotherapy Science <4564>, Fureasu <7062>, and Integral <5842> appearing among the top decliners.

On the other hand, DWTI <4576>, which completed administering doses to subjects in the domestic Phase II clinical trials of the regenerative medicine cell product "DWR-2206", surged by 38%, becoming the top gainer. Daiwa Cycle <5888> revised its full-year earnings forecast upward for the January 2025 period and hit a stop gain of 21%. Meanwhile, Hybrid Technologies <4260>, which acquired shares of NGSC for business expansion in Vietnam, rose by 9%. Among large market cap stocks, GNI Group <2160> and Free <4478> performed well, with Heartseed <219A>, Sakura Saku Plus <7097>, and POPER <5134> appearing among the top gainers.

In the TSE Growth Market Core Index, Trial, GENDA, and Cover <5253> declined.

[Tokyo Stock Exchange Growth Market Top 10 Stocks by Price Change]

・Top 10 by Price Increase

・Top 10 by Decline Rate